Global oncology/cancer drugs market to hit $335.2B by 2033 with 7.2% CAGR. Factors driving growth are awareness, cancer prevalence, and aging population.
The global market for oncology/cancer drugs is witnessing growth driven by several factors, including a growing awareness among the general population about available cancer treatment options, a notable increase in cancer prevalence worldwide, and a rise in the number of elderly individuals. These factors have contributed to a surge in demand for oncology drugs. Nonetheless, concerns persist regarding the adverse effects associated with these medications, highlighting the need for continued research and development in the field of cancer treatment.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments